Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis

Journal of Clinical Epidemiology

Volumn 54, Issue 10, 2001, Pages 1046-1055

  Sterne, Jonathan A C ^a   Egger, Matthias ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Funnel plot; Meta analysis; Publication bias; Randomized controlled trials; Selection bias; Statistical method; Systematic reviews

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MAGNESIUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEATH; ERROR; HEART INFARCTION; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SAMPLE; STATISTICAL ANALYSIS; VARIANCE;

DATA INTERPRETATION, STATISTICAL; GUIDELINES; HUMANS; MAGNESIUM; META-ANALYSIS; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS;

EID: 0034823867     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00377-8     Document Type: Article

References (39)

1. Publication bias in clinical research
2. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards
3. Publication bias; a problem in interpreting medical data
4. Misleading meta-analysis. Lessons from 'an effective, safe, simple' intervention that wasn't
5. Bias in meta-analysis detected by a simple, graphical test
6. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
7. Publication and related bias in meta-analysis; power of statistical tests and prevalence in the literature
8. Who benefits from medical interventions? Treating low risk patients can be a high risk strategy
9. Misleading funnel plot for detection of bias in meta-analysis
10. Effects of intravenous magnesium in suspected acute myocardial infarction; overview of randomised trials
11. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality; meta-analysis of magnesium in acute myocardial infarction
12. ISIS-4; A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
13. Random-effects meta-analyses are not always conservative
14. Long term outcome after magnesium sulphate in suspected acute myocardial infarction; The Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
15. Measured enthusiasm; does the method of reporting trial results alter perceptions of therapeutic effectiveness?
16. Operating characteristics of a rank correlation test for publication bias
17. sbe19.1; Tests for publication bias in meta-analysis
18. Investigating and dealing with publication and other biases
19. Meta-analysis; bias in location and selection of studies
20. Publication bias; evidence of delayed publication in a cohort study of clinical research projects
21. How important is publication bias? A synthesis of available data
22. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
23. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease; a meta-analysis of randomized trials
24. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension
25. Large trials vs meta-analysis of smaller trials. How do their results compare?
26. A comparison of methods to detect publication bias in meta-analysis
27. What works? Selectivity models and meta-analysis
28. Reanalysis of epidemiological evidence on lung cancer and passive smoking
29. Publication bias; the case for an international registry of clinical trials
30. Meta-analysis of the literaure or of individual patient data; is there a difference?
31. The fate of abstracts submitted to a cancer meeting; factors which influence presentation and subsequent publication
32. Full publication of results initially presented in abstracts. A meta-analysis
33. NIH clinical trials and publication bias
34. Effect measures for meta-analysis of trials with binary outcomes
35. Choosing an appropriate dichotomous effect measure for meta-analysis; empirical evidence of the appropriateness of the odds ratio and relative risk
36. Heterogeneity and statistical significance in meta-analysis; an empirical study of 125 meta-analyses
37. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
38. Effects of enalapril on mortality in severe congestive heart failure